Shilpa Medicare receives initial authorization for Rotigotine transdermal patch from Europe
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
Winlevi is authorized in EU for the treatment of acne vulgaris
This is the first drug to receive a recommendation for this preventative indication in the European Union
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Subscribe To Our Newsletter & Stay Updated